[ Price : $8.95]
FDA releases its latest batch of Warning Letters that includes one medical product company Vital Rx.[ Price : $8.95]
FDA accepts a Dova Pharmaceuticals supplemental NDA for Doptelet (avatrombopag) for treating chronic immune thrombocytopenia in pa...[ Price : $8.95]
Federal Register notice. FDA seeks comments on an information collection extension for its Guidance for Industry on Individual Pat...[ Price : $8.95]
FDA cautions Atlantic Pharmacy and Compounding about insanitary conditions in its production of drug products.[ Price : $8.95]
A CDRH Webinar explains provisions in a recent guidance on the appropriate use of voluntary consensus standards in premarket submi...[ Price : $8.95]
Sandoz decides not to pursue FDA approval for its proposed biosimilar of rituximab (Genentechs Rituxan), indicated for treating so...[ Price : $8.95]
FDA issues Lupin a five-item Form 483 after an inspection at the firms Madhya Pradesh, India manufacturing plant cited significant...[ Price : $8.95]
FDA clears a NinePoint Medical 510(k) to market its Intelligent Real-time Image Segmentation software upgrade for its NvisionVLE I...